/
ATRA
$8.02-$0.49 (-5.76%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$83.1M
9M shares
52-week range
$3.92 – $19.15
27% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-302.23
Atara Biotherapeutics, Inc
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
www.atarabio.com- Employees
- 13
- IPO / List date
- Oct 16, 2014
- HQ
- THOUSAND OAKS, CA
Held by traders on TradeandTell
No one on the platform currently holds ATRA.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 30,040 | $543.4K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-06-20 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded ATRA yet.
